Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by HOFFMANN LA ROCHE

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
018662 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020073 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020628 New Drug Application Approval New molecular entity (NME) (P*) Priority review drug*
020766 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020828 New Drug Application Approval New formulation (P) Priority review drug
020896 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
021304 New Drug Application Approval New ester, new salt, or other noncovalent derivative (P) Priority review drug
021455 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
022257 New Drug Application Approval New formulation (P) Priority review drug
050585 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
050624 New Drug Application Approval New formulation (S) Standard review drug
062654 Abbreviated New Drug Application Approval
063239 Abbreviated New Drug Application Approval
202429 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug

Back to Companies who have applied for FDA Drug Approval